Prediction of clinical outcomes with the pathway-based risk score model in melanoma. (A) PMPscore heatmap of candidate pathways. (B) Kaplan–Meier survival curves of OS comparing the high- and low-risk groups from the melanoma training cohort. (C) Comparison of the ORR between the high- and low-risk groups from the melanoma training cohort.